Skip to Main Content

Paper Details

Plasma pre-treatment T790M relative allelic frequency in patients with advanced EGFR-mutated non-small cell lung cancer predicts treatment response to subsequent-line osimertinib.
Transl Lung Cancer Res
5
2021
Author NameAffiliation
Bo GaoWestmead and Blacktown Cancer Centre
Thomas JohnPeter MacCallum Cancer Centre
  • 1 - 2

Datasets

Release 1.2